NYLI Balanced Class R6 holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
NYLI Balanced Class R6 MBERX
- NAV / 1-Day Return 33.23 / −0.09 %
- Total Assets 446.4M
-
Adj. Expense Ratio
0.730%
- Expense Ratio 0.720%
- Distribution Fee Level Above Average
- Share Class Type Retirement, Large
- Category Moderate Allocation
- Investment Style Large Value
- Credit Quality / Interest Rate Sensitivity Medium/Limited
- Status Open
- TTM Yield 2.23%
- Turnover 201%
USD | NAV as of Jul 16, 2026 | 1-Day Return as of Jul 16, 2026, 12:11 AM GMT+0
Morningstar’s Analysis MBERX
Will MBERX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 28.2
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
United States Treasury Notes 3.75% | 4.41 | 20M | Government |
iShares Intermediate Govt/Crdt Bd ETF | 3.79 | 17M | — |
Vanguard Intmdt-Term Trs ETF | 3.64 | 16M | — |
Alphabet Inc Class C | 3.31 | 15M | Communication Services |
United States Treasury Notes 4.125% | 3.20 | 14M | Government |
United States Treasury Notes 3.875% | 2.36 | 11M | Government |
United States Treasury Notes 3.875% | 2.20 | 10M | Government |
JPMorgan Chase & Co | 2.15 | 10M | Financial Services |
Merck & Co Inc | 1.60 | 7M | Healthcare |
Johnson & Johnson | 1.58 | 7M | Healthcare |